Page last updated: 2024-10-31

moclobemide and Plasmodium falciparum Malaria

moclobemide has been researched along with Plasmodium falciparum Malaria in 2 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prado-Prado, F1
García-Mera, X1
Escobar, M1
Sobarzo-Sánchez, E1
Yañez, M1
Riera-Fernandez, P1
González-Díaz, H1
Miller, ME1
Parrott, EE1
Singh, R1
Nelson, SW1

Other Studies

2 other studies available for moclobemide and Plasmodium falciparum Malaria

ArticleYear
2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:12

    Topics: Antiprotozoal Agents; Aporphines; Databases, Factual; Humans; Ligands; Malaria, Falciparum; Markov C

2011
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
    Journal of biomolecular screening, 2014, Volume: 19, Issue:6

    Topics: Antimalarials; Apicoplasts; Chloroplasts; DNA; DNA-Directed DNA Polymerase; Drug Discovery; Exonucle

2014